170 related articles for article (PubMed ID: 30037548)
1. Re-engineering of an Escherichia coli K-12 strain for the efficient production of recombinant human Interferon Gamma.
Pandey R; Kumar N; Monteiro GA; Veeranki VD; Prazeres DMF
Enzyme Microb Technol; 2018 Oct; 117():23-31. PubMed ID: 30037548
[TBL] [Abstract][Full Text] [Related]
2. Effect of iclR and arcA knockouts on biomass formation and metabolic fluxes in Escherichia coli K12 and its implications on understanding the metabolism of Escherichia coli BL21 (DE3).
Waegeman H; Beauprez J; Moens H; Maertens J; De Mey M; Foulquié-Moreno MR; Heijnen JJ; Charlier D; Soetaert W
BMC Microbiol; 2011 Apr; 11():70. PubMed ID: 21481254
[TBL] [Abstract][Full Text] [Related]
3. Increasing recombinant protein production in Escherichia coli K12 through metabolic engineering.
Waegeman H; De Lausnay S; Beauprez J; Maertens J; De Mey M; Soetaert W
N Biotechnol; 2013 Jan; 30(2):255-61. PubMed ID: 22115732
[TBL] [Abstract][Full Text] [Related]
4. Solubility of disulfide-bonded proteins in the cytoplasm of Escherichia coli and its "oxidizing" mutant.
Xiong S; Wang YF; Ren XR; Li B; Zhang MY; Luo Y; Zhang L; Xie QL; Su KY
World J Gastroenterol; 2005 Feb; 11(7):1077-82. PubMed ID: 15742420
[TBL] [Abstract][Full Text] [Related]
5. Plasmid DNA production with Escherichia coli GALG20, a pgi-gene knockout strain: fermentation strategies and impact on downstream processing.
Gonçalves GA; Prather KL; Monteiro GA; Carnes AE; Prazeres DM
J Biotechnol; 2014 Sep; 186():119-27. PubMed ID: 24995846
[TBL] [Abstract][Full Text] [Related]
6. Effect of iclR and arcA deletions on physiology and metabolic fluxes in Escherichia coli BL21 (DE3).
Waegeman H; Maertens J; Beauprez J; De Mey M; Soetaert W
Biotechnol Lett; 2012 Feb; 34(2):329-37. PubMed ID: 22009573
[TBL] [Abstract][Full Text] [Related]
7. Identification of riboflavin: revealing different metabolic characteristics between Escherichia coli BL21(DE3) and MG1655.
Wang X; Wang Q; Qi Q
FEMS Microbiol Lett; 2015 Jun; 362(11):. PubMed ID: 25926527
[TBL] [Abstract][Full Text] [Related]
8. High-level production of membrane proteins in E. coli BL21(DE3) by omitting the inducer IPTG.
Zhang Z; Kuipers G; Niemiec Ł; Baumgarten T; Slotboom DJ; de Gier JW; Hjelm A
Microb Cell Fact; 2015 Sep; 14():142. PubMed ID: 26377812
[TBL] [Abstract][Full Text] [Related]
9. [Influence of the reductase deficient Escherichia coli on the solubility of recombinant proteins produced in it].
Xiong S; Zhang MY; Qian CW; Ran YC; Wang YF; Ren XR; Su KY; Yu ZY
Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):686-91. PubMed ID: 15971580
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of three industrial Escherichia coli strains in fed-batch cultivations during high-level SOD protein production.
Marisch K; Bayer K; Cserjan-Puschmann M; Luchner M; Striedner G
Microb Cell Fact; 2013 Jun; 12():58. PubMed ID: 23758670
[TBL] [Abstract][Full Text] [Related]
11. Production of 3-O-xylosyl quercetin in Escherichia coli.
Pandey RP; Malla S; Simkhada D; Kim BG; Sohng JK
Appl Microbiol Biotechnol; 2013 Mar; 97(5):1889-901. PubMed ID: 23053089
[TBL] [Abstract][Full Text] [Related]
12. [Effects of knockout genes related to outer membrane on extracellular secretion of recombinant proteins in Escherichia coli BL21 (DE3)].
Zhu Y; Zhou Y; Chu J; He B
Wei Sheng Wu Xue Bao; 2015 Dec; 55(12):1551-9. PubMed ID: 27101697
[TBL] [Abstract][Full Text] [Related]
13. Recombinant protein production provoked accumulation of ATP, fructose-1,6-bisphosphate and pyruvate in E. coli K12 strain TG1.
Weber J; Li Z; Rinas U
Microb Cell Fact; 2021 Aug; 20(1):169. PubMed ID: 34446023
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic analysis of riboswitch containing E. coli recombinant expression system.
Muhamadali H; Xu Y; Morra R; Trivedi DK; Rattray NJ; Dixon N; Goodacre R
Mol Biosyst; 2016 Feb; 12(2):350-61. PubMed ID: 26621574
[TBL] [Abstract][Full Text] [Related]
15. Escherichia coli phosphoglucose isomerase can be substituted by members of the PGI family, the PGI/PMI family, and the cPGI family.
Hansen T; Schönheit P
FEMS Microbiol Lett; 2005 Sep; 250(1):49-53. PubMed ID: 16046082
[TBL] [Abstract][Full Text] [Related]
16. Use of a derivative of Escherichia coli BL21(DE3) for efficient production of three different recombinant proteins.
Zhao JB; Wei DZ
Biotechnol Prog; 2007; 23(5):1043-8. PubMed ID: 17715940
[TBL] [Abstract][Full Text] [Related]
17. Fermentation characteristics and protein expression patterns in a recombinant Escherichia coli mutant lacking phosphoglucose isomerase for poly(3-hydroxybutyrate) production.
Kabir MM; Shimizu K
Appl Microbiol Biotechnol; 2003 Aug; 62(2-3):244-55. PubMed ID: 12883871
[TBL] [Abstract][Full Text] [Related]
18. De novo creation of MG1655-derived E. coli strains specifically designed for plasmid DNA production.
Gonçalves GA; Prazeres DM; Monteiro GA; Prather KL
Appl Microbiol Biotechnol; 2013 Jan; 97(2):611-20. PubMed ID: 22885693
[TBL] [Abstract][Full Text] [Related]
19. [Construction of the new Escherichia coli K-12 wild-type strain with improved growth characteristics for application in metabolic engineering].
Biriukova IV; Krylov AA; Kiseleva EM; Minaeva NI; Mashko SV
Genetika; 2010 Mar; 46(3):349-55. PubMed ID: 20391779
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of recombinant human proteins with the Escherichia coli strain Rosetta(DE3).
Tegel H; Tourle S; Ottosson J; Persson A
Protein Expr Purif; 2010 Feb; 69(2):159-67. PubMed ID: 19733669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]